Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain

References

• Barstow, C.; Rice, M.; McDivitt, J. D. Acute Coronary Syndrome: Diagnostic Evaluation. Am. Fam. Physician. 2017, 95, 3, 170–177.
   PubMed Web of Science ®Google Scholar
• Makki, N.; Brennan, T. M.; Girotra, S. Acute Coronary Syndrome. J. Intensive Care Med. 2015, 30(4), 186–200. DOI: 10.1177/0885066613503294.
   PubMed Web of Science ®Google Scholar
• Berry, C.; Corcoran, D.; Hennigan, B.; Watkins, S.; Layland, J.; Oldroyd, K. G. Fractional Flow Reserve-Guided Management in Stable Coronary Disease and Acute Myocardial Infarction: Recent Developments. Eur. Heart J. 2015, 36(45), 3155–3164. DOI: 10.1093/eurheartj/ehv206.
   PubMed Web of Science ®Google Scholar
• Asaria, P.; Elliott, P.; Douglass, M.; Obermeyer, Z.; Soljak, M.; Majeed, A.; Ezzati, M. Acute Myocardial Infarction Hospital Admissions and Deaths in England: A National Follow-Back and Follow-Forward Record-Linkage Study. Lancet Public Health 2017, 2(4), e191–e201. DOI: 10.1016/S2468-2667(17)30032-4.
   PubMed Web of Science ®Google Scholar
• Čolak, T.; Mikulić, I.; Landeka, K.; Sesar, A.; Vranješ, M.; Mikulić, I. Predictive Value of High Sensitive Troponin I Assay in Acute Coronary Syndrome Compared to Classic Biochemical Markers. Psychiatr. Danub. 2017, 29, Suppl 4, 823–829.
   PubMedGoogle Scholar
• Mauro, M. S.; Nelson, A. J.; Stokes, M. B. Troponin Testing in the Primary Care Setting. Aust. Fam. Physician. 2017, 46, 11, 823–826.
   PubMed Web of Science ®Google Scholar
• Kounis, N. G.; Soufras, G. D.; Tsigkas, G.; Hahalis, G. White Blood Cell Counts, Leukocyte Ratios, and Eosinophils as Inflammatory Markers in Patients with Coronary Artery Disease. Clin. Appl. Thromb. Hemost. 2015, 21(2), 139–143. DOI: 10.1177/1076029614531449.
   PubMed Web of Science ®Google Scholar
• Calmarza, P.; Lapresta, C.; Martínez, M.; Lahoz, R.; Povar, J. Utility of Myeloperoxidase in the Differential Diagnosis of Acute Coronary Syndrome. Arch. Cardiol. Mex. 2017, S1405–9940, 17, 30121.
   Google Scholar
• Griner, P. F.; Mayewski, R. J.; Mushlin, A. I.; Greenland, P. Selection and Interpretation of Diagnostic Tests and Procedures. Principles and Applications. Ann. Intern. Med. 1981, 94, 557–592.
   PubMed Web of Science ®Google Scholar
• Govindarajan, S.; Raghavan, V. M.; Rao, A. C. Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome. J. Clin. Diagn. Res. 2016, 10, 8, BC09–BC13.
   PubMed Web of Science ®Google Scholar
• Tretjakovs, P.; Jurka, A.; Bormane, I.; Mikelsone, I.; Elksne, K.; Krievina, G.; Reihmane, D.; Verbovenko, J.; Bahs, G. Circulating Adhesion Molecules, Matrix Metalloproteinase-9, Plasminogen Activator Inhibitor-1, and Myeloperoxidase in Coronary Artery Disease Patients with Stable and Unstable Angina. Clinica Chimica Acta 2012, 413(1–2), 25–29. DOI: 10.1016/j.cca.2011.10.009.
   PubMed Web of Science ®Google Scholar
• Goldmann, B. U.; Rudolph, V.; Rudolph, T. K.; Holle, A. K.; Hillebrandt, M.; Meinertz, T.; Baldus, S. Neutrophil Activation Precedes Myocardial Injury in Patients with Acute Myocardial Infarction. Free Radic. Biol. Med. 2009, 47(1), 79–83. DOI: 10.1016/j.freeradbiomed.2009.04.004.
   PubMed Web of Science ®Google Scholar
• Rudolph, V.; Keller, T.; Schulz, A.; Ojeda, F.; Rudolph, T. K.; Tzikas, S.; Bickel, C.; Meinertz, T.; Münzel, T.; Blankenberg, S.; Baldus, S. Diagnostic and Prognostic Performance of Myeloperoxidase Plasma Levels Compared with Sensitive Troponins in Patients Admitted with Acute Onset Chest Pain. Circ. Cardiovasc. Genet. 2012, 5, 561–568. DOI: 10.1161/CIRCGENETICS.111.962290.
   PubMed Web of Science ®Google Scholar
• Searle, J.; Shih, J.; Muller, R.; Vollert, J. O.; Müller, C.; Danne, O.; Datwyler, S.; Möcke, M. The Role of Myeloperoxidase (MPO) for Prognostic Evaluation in Sensitive Cardiac Troponin I Negative Chest Pain Patients in the Emergency Department. Eur. Heart J. 2013, 2, 3, 203–210.
   Google Scholar
• Stiermaier, T.; Thiele, H.; Eitel, I. Clinical Utility of Novel Biomarkers in Acute Myocardial Infarction. Ann. Transl. Med. 2016, 4(24), 491. DOI: 10.21037/atm.2016.04.05.
   PubMed Web of Science ®Google Scholar
• Reindl, M.; Reinstadler, S. J.; Feistritzer, H. J.; Mueller, L.; Koch, C.; Mayr, A.; Theurl, M.; Kirchmair, R.; Klug, G.; Metzler, B. Fibroblast Growth Factor 23 as Novel Biomarker for Early Risk Stratification after ST-elevation Myocardial Infarction. Heart 2017, 103(11), 856–862. DOI: 10.1136/heartjnl-2016-310520.
   PubMed Web of Science ®Google Scholar
• Boeddinghaus, J.; Reichlin, T.; Nestelberger, T.; Twerenbold, R.; Meili, Y.; Wildi, K.; Hillinger, P.; Giménez, M. R.; Cupa, J.; Schumacher, L.; Schubera, M.; Badertscher, P.; Corbière, S.; Grimm, K.; Puelacher, C.; Sabti, Z.; Widmer, D. F.; Schaerli, N.; Kozhuharov, N.; Shrestha, S.; Bürge, T.; Mächler, P.; Büchi, M.; Rentsch, K.; Miró, Ò.; López, B.; Martin-Sanchez, F. J.; Rodriguez-Adrada, E.; Morawiec, B.; Kawecki, D.; Ganovská, E.; Parenica, J.; Lohrmann, J.; Buser, A.; Keller, D.; Osswald, S.; Mueller, C. Early Diagnosis of Acute Myocardial Infarction in Patients with Mild Elevations of Cardiac Troponin. Clin. Res. Cardiol. 2017, 106(6), 457–467. DOI: 10.1007/s00392-016-1075-9.
   PubMed Web of Science ®Google Scholar
• Hamza, M.; Demerdash, S.; Ibrahim, M. Heart-Type Fatty Acid-Binding Protein as a Diagnostic Biochemical Marker for Early Detection of Myocardial Infarction. Acta Cardiol. 2016, 71(5), 537–541. DOI: 10.2143/AC.71.5.3167496.
   PubMed Web of Science ®Google Scholar
• Mythili, S.; Malathi, N. Diagnostic Markers of Acute Myocardial Infarction. Biomed. Rep. 2015, 3(6), 743–748. DOI: 10.3892/br.2015.500.
   PubMed Web of Science ®Google Scholar
• Rudolph, V.; Goldmann, B. U.; Bös, C.; Rudolph, T. K.; Klinke, A.; Friedrichs, K.; Lau, D.; Wegscheider, K.; Haddad, M.; Meinertz, T.; Baldus, S. Diagnostic Value of MPO Plasma Levels in Patients Admitted for Suspected Myocardial Infarction. Int. J. Cardiol. 2011, 153(3), 267–271. DOI: 10.1016/j.ijcard.2010.08.015.
   PubMed Web of Science ®Google Scholar
• Vupputuri, A.; Sekhar, S.; Krishnan, S.; Venugopal, K.; Natarajan, K. U. Heart-Type Fatty Acid-Binding Protein (H-FABP) as an Early Diagnostic Biomarker in Patients with Acute Chest Pain. Indian Heart J. 2015, 67(6), 538–542. DOI: 10.1016/j.ihj.2015.06.035.
   PubMedGoogle Scholar
• Kabekkodu, S. P.; Mananje, S. R.; Saya, R. P. A. Study on the Role of Heart Type Fatty Acid Binding Protein in the Diagnosis of Acute Myocardial Infarction. J. Clin. Diagn. Res. 2016, 10, 1, OC07–10.
   PubMed Web of Science ®Google Scholar
• Janković, R.; Marković, D.; Savić, N.; Dinić, V. Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers. BioMed. Res. Internationa. 2015, Article ID 187384, 8.
   Google Scholar
• Stengaard, C.; Sørensen, J. T.; Ladefoged, S. A.; Lassen, J. F.; Rasmussen, M. B.; Pedersen, C. K.; Ayer, A.; Bøtker, H. E.; Terkelsen, C. J.; Thygesen, K. The Potential of Optimizing Prehospital Triage of Patients with Suspected Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T and Copeptin. Biomarkers 2017, 22(3–4), 351–360. DOI: 10.1080/1354750X.2016.1265008.
   PubMed Web of Science ®Google Scholar
• Yanishi, K.; Nakamura, T.; Nakanishi, N.; Yokota, I.; Zen, K.; Yamano, T.; Shiraishi, H.; Shirayama, T.; Shiraishi, J.; Sawada, T.; Kohno, Y.; Kitamura, M.; Furukawa, K.; Matoba, S. A Simple Risk Stratification Model for ST-Elevation Myocardial Infarction (STEMI) from the Combination of Blood Examination Variables: Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group. PLoS ONE 2016, 11(11), e0166391. DOI: 10.1371/journal.pone.0166391.
   PubMed Web of Science ®Google Scholar
• O’Donoghue, M. L.; Morrow, D. A.; Cannon, C. P.; Jarolim, P.; Desai, N. R.; Sherwood, M. W.; Murphy, S. A.; Gerszten, R. E.; Sabatine, M. S. Multimarker Risk Stratification in Patients with Acute Myocardial Infarction. J. Am. Heart Assoc. 2016, 5, e002586. DOI: 10.1161/JAHA.115.002586.
   PubMed Web of Science ®Google Scholar